Size transformations of intermediate and low density lipoproteins induced by unesterified fatty acids.
Plasma from individual human subjects is known to contain multiple discrete subpopulations of low (LDL) and intermediate (IDL) density lipoproteins that differ in particle size and density. The metabolic origins of these subpopulations are unknown. Transformation of IDL and larger LDL to smaller, denser LDL particles had been postulated to occur as a result of the combined effects of triglyceride hydrolysis and lipid transfer. However, the presence of multiple small LDL subspecies has been described in patients lacking cholesteryl ester transfer protein. We have characterized an alternative pathway in which size decrements in IDL or LDL are produced in the presence of unesterified fatty acids and a source of apolipoprotein (apo) A-I. Incubation of IDL or LDL subfractions with palmitic acid and either high density lipoproteins (HDL), apoHDL, or purified apoA-I gives rise to apoA-I, apoB-containing complexes that can dissociate into two particles, an apoB-containing lipoprotein with particle diameter 10-30 A smaller than the starting material, and a still smaller species (apparent peak particle diameter 140-190 A) containing lipid and apoA-I but no apoB. The newly formed IDL or LDL are depleted in phospholipid and free cholesterol with no change in apoB-100 as assessed by SDS gel electrophoresis. We hypothesize that this reaction may contribute to the formation of discrete IDL and LDL subpopulations of varying size during the course of hydrolysis of triglyceride-rich lipoproteins in plasma.
Musliner
T A
TA
Research Medicine and Radiation Biophysics Division, University of California, Berkeley 94720.
Long
M D
MD
Forte
T M
TM
Krauss
R M
RM
D016632:Apolipoprotein A-I / Q000302:isolation & purification / Q000502:physiology; D001055:Apolipoproteins B / Q000097:blood; D002499:Centrifugation, Density Gradient; D002784:Cholesterol / Q000096:biosynthesis* / Q000097:blood; D005230:Fatty Acids, Nonesterified / Q000502:physiology*; D006801:Humans; D008074:Lipoproteins / Q000096:biosynthesis* / Q000097:blood; D008075:Lipoproteins, HDL / Q000502:physiology; D008077:Lipoproteins, LDL / Q000096:biosynthesis* / Q000097:blood; D010316:Particle Size
D016632:Apolipoprotein A-I; D001055:Apolipoproteins B; D005230:Fatty Acids, Nonesterified; D008074:Lipoproteins; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; C030104:lipoprotein cholesterol; D002784:Cholesterol